Viewing Study NCT00645268


Ignite Creation Date: 2025-12-24 @ 5:50 PM
Ignite Modification Date: 2026-02-21 @ 10:34 AM
Study NCT ID: NCT00645268
Status: COMPLETED
Last Update Posted: 2021-02-01
First Post: 2008-03-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module